An Open-Label, Escalating Dose, Single Center, Cross-Over Design, Phase I Study to Evaluate Menses Induction in Women Administered Proellex.

Trial Profile

An Open-Label, Escalating Dose, Single Center, Cross-Over Design, Phase I Study to Evaluate Menses Induction in Women Administered Proellex.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 21 Oct 2014

At a glance

  • Drugs Telapristone (Primary)
  • Indications Menstruation disorders
  • Focus Pharmacodynamics
  • Sponsors Repros Therapeutics
  • Most Recent Events

    • 12 Feb 2010 Actual patient number (11) added as reported by ClinicalTrials.gov.
    • 12 Aug 2009 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 03 Aug 2009 Status changed from active, no longer recruiting to suspended, according to a Repros Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top